Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · IEX Real-Time Price · USD
20.59
+2.33 (12.76%)
At close: Apr 23, 2024, 4:00 PM
21.00
+0.41 (1.99%)
Pre-market: Apr 24, 2024, 4:00 AM EDT
Cartesian Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for RNAC stock have an average target of 27.67, with a low estimate of 2.00 and a high estimate of 42. The average target predicts an increase of 34.39% from the current stock price of 20.59.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RNAC stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '24 | Apr '24 |
|---|---|---|
| Strong Buy | 1 | 2 |
| Buy | 0 | 1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 1 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $54 → $2 | Strong Buy | Maintains | $54 → $2 | -90.29% | Apr 23, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $39 | Buy | Initiates | $39 | +89.41% | Apr 23, 2024 |
| Needham | Needham | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +103.98% | Apr 10, 2024 |
| Needham | Needham | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +103.98% | Apr 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +191.40% | Mar 18, 2024 |
Financial Forecast
Revenue This Year
34.17M
from 26.00M
Increased by 31.40%
Revenue Next Year
50.74M
from 34.17M
Increased by 48.50%
EPS This Year
-3.98
from -49.80
EPS Next Year
-1.53
from -3.98
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | 49.4M | 52.2M |
| Avg | 34.2M | 50.7M |
| Low | 19.6M | 48.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | 89.8% | 52.9% |
| Avg | 31.4% | 48.5% |
| Low | -24.6% | 42.7% |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -1.58 | -1.58 |
| Avg | -3.98 | -1.53 |
| Low | -6.17 | -1.47 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.